IBDEI0VC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15226,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,15226,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,15226,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,15227,0)
 ;;=332.0^^81^941^88
 ;;^UTILITY(U,$J,358.3,15227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15227,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,15227,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,15227,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,15228,0)
 ;;=250.60^^81^941^89
 ;;^UTILITY(U,$J,358.3,15228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15228,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,15228,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,15228,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,15229,0)
 ;;=356.9^^81^941^91
 ;;^UTILITY(U,$J,358.3,15229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15229,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,15229,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,15229,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,15230,0)
 ;;=780.2^^81^941^106
 ;;^UTILITY(U,$J,358.3,15230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15230,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,15230,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,15230,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,15231,0)
 ;;=724.3^^81^941^102
 ;;^UTILITY(U,$J,358.3,15231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15231,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,15231,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,15231,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,15232,0)
 ;;=780.39^^81^941^103
 ;;^UTILITY(U,$J,358.3,15232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15232,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,15232,1,5,0)
 ;;=5^Seizure
 ;;^UTILITY(U,$J,358.3,15232,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,15233,0)
 ;;=782.0^^81^941^87
 ;;^UTILITY(U,$J,358.3,15233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15233,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,15233,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,15233,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,15234,0)
 ;;=435.9^^81^941^107
 ;;^UTILITY(U,$J,358.3,15234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15234,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,15234,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,15234,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,15235,0)
 ;;=354.2^^81^941^109
 ;;^UTILITY(U,$J,358.3,15235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15235,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,15235,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,15235,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,15236,0)
 ;;=729.1^^81^941^35
 ;;^UTILITY(U,$J,358.3,15236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15236,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,15236,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,15236,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,15237,0)
 ;;=438.20^^81^941^11
 ;;^UTILITY(U,$J,358.3,15237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15237,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,15237,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,15237,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,15238,0)
 ;;=438.12^^81^941^8
 ;;^UTILITY(U,$J,358.3,15238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15238,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,15238,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,15238,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,15239,0)
 ;;=356.8^^81^941^90
 ;;^UTILITY(U,$J,358.3,15239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15239,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,15239,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;
 ;;$END ROU IBDEI0VC
